1. Home
  2. GORO vs ACHV Comparison

GORO vs ACHV Comparison

Compare GORO & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gold Resource Corporation

GORO

Gold Resource Corporation

HOLD

Current Price

$1.49

Market Cap

212.0M

ML Signal

HOLD

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

HOLD

Current Price

$3.46

Market Cap

172.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GORO
ACHV
Founded
1998
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
212.0M
172.0M
IPO Year
2010
2018

Fundamental Metrics

Financial Performance
Metric
GORO
ACHV
Price
$1.49
$3.46
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$1.63
$15.50
AVG Volume (30 Days)
1.7M
798.1K
Earning Date
05-11-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
91.80
N/A
EPS
N/A
N/A
Revenue
$99,759,000.00
N/A
Revenue This Year
$25.99
N/A
Revenue Next Year
$5.78
N/A
P/E Ratio
N/A
N/A
Revenue Growth
51.78
N/A
52 Week Low
$0.35
$1.95
52 Week High
$1.87
$6.03

Technical Indicators

Market Signals
Indicator
GORO
ACHV
Relative Strength Index (RSI) 63.35 47.20
Support Level $1.27 $2.59
Resistance Level $1.75 $3.90
Average True Range (ATR) 0.10 0.25
MACD 0.04 0.06
Stochastic Oscillator 79.57 55.27

Price Performance

Historical Comparison
GORO
ACHV

About GORO Gold Resource Corporation

Gold Resource Corp is a producer of metal concentrates that contain gold, silver, copper, lead, and zinc in Oaxaca, Mexico. . It targets low capital expenditure projects with the potential for generating high returns on capital. The company's two pipeline projects are; Don David Gold at Oaxaca, Mexico, and Back Forty at Michigan, United States of America. The Company has two reporting segments, based on geographic regions. Oaxaca, Mexico represents the Company's only operating segment with a production stage property. The Company's other reporting segment is Michigan, U.S.A., with an exploration stage property.

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

Share on Social Networks: